FIELD: medicine.
SUBSTANCE: method involves blood analysis with measuring the blood plasma viscosity in the patient prior to initiation of treatment. The value not exceeding 1.8 sP shows favourable fate implying potential full treatment, regression of primary tumour and regional metastases more than 75%, while the value 1.8 sP indicates probable severe complications, resistance of tumour and progression of disease with underlying treatment.
EFFECT: reduction in price and time of analysis.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INDIVIDUAL THERAPY RESULT FORECAST FOR LOCALLY ADVANCED MALIGNANT TUMOUR OF OROPHARYNGEAL AREA | 2008 |
|
RU2371724C1 |
| METHOD FOR TREATING PATIENTS WITH TOPICALLY METASTASING PHARYNGEAL CANCER | 2005 |
|
RU2289364C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF CONSERVATIVE TREATMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2023 |
|
RU2817324C1 |
| METHOD FOR TREATMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2007 |
|
RU2347591C1 |
| METHOD OF TREATING LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2009 |
|
RU2401139C1 |
| METHOD FOR PREDICTION OF RELAPSE DEVELOPMENT IN PATIENTS WITH ORAL MUCOSA CANCER | 2016 |
|
RU2635535C1 |
| METHOD FOR PREDICTING THE OUTCOME OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND OROPHARYNX | 2019 |
|
RU2708786C1 |
| METHOD FOR PREDICTING TUMOUR RESISTANCE TO TETHEGETH THERAPY OF CETUXIMAB IN PATIENTS WITH PLANE-CELLULAR LANGUAGE OF LANGUAGE AND MULTIDISAL BOTTOM OF THE PTA | 2016 |
|
RU2626682C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS AND CLINICAL COURSE OF NEOPLASTIC PROCESS IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA | 2012 |
|
RU2526830C2 |
| METHOD OF PREDICTION OF OUTCOMES IN PATIENTS WITH SQUAMOUS CELL CANCER OF THE ORAL MUCOSA | 2023 |
|
RU2802446C2 |
